Hwang Sooin 4
4 · Vincerx Pharma, Inc. · Filed Feb 16, 2022
Insider Transaction Report
Form 4
Hwang Sooin
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-14+34,000→ 34,000 totalExercise: $6.26Exp: 2032-02-13→ Common Stock (34,000 underlying)
Footnotes (1)
- [F1]Option vests over three years, with 1/3 of the shares vesting on December 23, 2022, and 1/36th of the shares vesting monthly thereafter.